Ethics approval has been submitted. That was acknowledged by David in the very recent investor update.
They were expecting a reply around Christmas. I'd posit that while it's still very early January and there are breaks over Christmas and new year, timing is fair.
If biotech were analogous to a mining operation, then the concern with "deadlines" would be apt. But it's not. It's an evolving scientific beast. One which we've continued to throw expertise towards with new hires and a massive funding program.
I'd posit that most long term holders understand this reality.
General Comments / Chat, page-4828
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.68 |
Change
0.125(8.06%) |
Mkt cap ! $277.8M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.75 | $1.61 | $584.5K | 348.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 666 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 2700 | 2 |
View Market Depth
| Last trade - 14.26pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.67 |
Change
0.125 ( 8.94 %) |
||||
| Open | High | Low | Volume | ||
| $1.64 | $1.73 | $1.63 | 29172 | ||
| Last updated 14.35pm 14/05/2024 ? | |||||
| RAC (ASX) Chart |